AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Opportunity Assessment of the Global Dry Eye Syndrome Market (2019-2024): Segmented by Disease, Drug, Product, Distribution Channel and Region - ResearchAndMarkets.com

March 7, 2019

DUBLIN--(BUSINESS WIRE)--Mar 7, 2019--The “Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering.

The global dry eye syndrome market was worth US$ 3.5 Billion in 2018. Looking forward, the market value is projected to reach US$ 5.1 Billion by 2024, exhibiting a CAGR of 6.5% during 2019-2024.

There are several factors that can cause dry eye syndrome such as excessive computer use, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

Various diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people.

As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient’s blood which adversely affects the tear glands resulting in a rising prevalence of dry eye.

Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population.

With the prevalence of dry eyes being fairly high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.

Key Questions Answered

  • How has the global dry eye syndrome market performed so far and how will it perform in the coming years?
  • What is the breakup of the global dry eye syndrome market on the basis of region?
  • What is the breakup of the global dry eye syndrome market on the basis of disease type?
  • What is the breakup of the global dry eye syndrome market on the basis of drug type?
  • What is the breakup of the global dry eye syndrome market on the basis of product type?
  • What is the breakup of the global dry eye syndrome market on the basis of distribution channel?
  • What are the various stages in the value chain of the global dry eye syndrome market?
  • What are the key driving factors and challenges in the global dry eye syndrome market?
  • What is the structure of the global dry eye syndrome market and who are the key players?
  • What is the degree of competition in the global dry eye syndrome market?

Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Properties

4.3 Key Industry Trends

5 Global Dry Eye Syndrome Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Disease Type

5.4 Market Breakup by Drug Type

5.5 Market Breakup by Product

5.6 Market Breakup by Distribution Channels

5.7 Market Breakup by Region

5.8 Market Forecast

6 Market Breakup by Disease Type

6.1 Evaporative Dry Eye Syndrome

6.2 Aqueous Dry Eye Syndrome

7 Market Breakup by Drug Type

7.1 Lubricant Eye Drops

7.2 Anti-inflammatory Drugs

7.3 Autologous Serum Eye Drops

8 Market Breakup by Product

8.1 Liquid Drops

8.2 Gel

8.3 Liquid Wipes

8.4 Eye Ointment

8.5 Others

9 Market Breakup by Distribution Channel

9.1 Retail Pharmacies

9.2 Hospital Pharmacies

9.3 Online Pharmacies

10 Market Breakup by Region

10.1 North America

10.2 Europe

10.3 Asia Pacific

10.4 Middle East and Africa

10.5 Latin America

11 Global Dry Eye Syndrome Industry: SWOT Analysis

11.1 Overview

11.2 Strengths

11.3 Weaknesses

11.4 Opportunities

11.5 Threats

12 Global Dry Eye Syndrome Industry: Value Chain Analysis

13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis

13.1 Overview

13.2 Bargaining Power of Buyers

13.3 Bargaining Power of Suppliers

13.4 Degree of Competition

13.5 Threat of New Entrants

13.6 Threat of Substitutes

14 Global Dry Eye Syndrome Industry: Price Analysis

14.1 Price Indicators

14.2 Price Structure

14.3 Margin Analysis

15 Manufacturing Process

15.1 Product Overview

15.2 Raw Material Requirements

15.3 Manufacturing Process

15.4 Key Success and Risk Factors

16 Competitive Landscape

16.1 Market Structure

16.2 Key Players

16.3 Profiles of Key Players

16.3.1 Novartis AG

16.3.2 Allergan PLC

16.3.3 Otsuka Holdings Co. Ltd.

16.3.4 Santen Pharmaceutical Co. Ltd.

16.3.5 Nicox S.A.

16.3.6 Auven Therapeutics

16.3.7 Akorn Inc.

16.3.8 Bausch + Lomb

16.3.9 Alimera Science

16.3.10 GlaxoSmithKline PLC

For more information about this report visit https://www.researchandmarkets.com/research/534f27/opportunity?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190307005372/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical ,Optical Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH OPTICAL PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/07/2019 08:21 AM/DISC: 03/07/2019 08:21 AM

http://www.businesswire.com/news/home/20190307005372/en